The Calmer Co International Ltd (ASX:CCO) Share Price

Company Profile

Business description
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are; Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading) which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia and the rest from Fiji, and other regions.
Contact
96 Victoria Street
West End
BrisbaneQLD4101
AUS
T: +61 738441010
https://www.thecalmerco.com
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
30 June 2025
Employees

Recommended

Shares drop 17% after guidance is revised but we still see value.

Shane Ponraj | 09 January 2025

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Joseph Taylor | 09 January 2025

These undervalued stocks with reliable dividends are worth considering.

Susan Dziubinski | 08 January 2025

Index	Last price	Change	% Change
All Ordinaries	8,543.70	34.10	-0.40%
CAC 40	7,431.04	59.24	-0.79%
DAX 40	20,214.79	102.31	-0.50%
Dow JONES (US)	41,938.45	696.75	-1.63%
FTSE 100	8,248.49	71.20	-0.86%
HKSE	19,064.29	176.60	-0.92%
NASDAQ	19,161.63	317.25	-1.63%
Nikkei 225	39,190.40	414.69	-1.05%
NZX 50 Index	12,895.98	47.76	-0.37%
S&P 500	5,827.04	91.21	-1.54%
S&P/ASX 200	8,294.10	35.10	-0.42%
SSE Composite Index	3,168.52	42.87	-1.33%